Fractyl Health, Inc. (NASDAQ:GUTS – Get Free Report) was the recipient of a significant growth in short interest in July. As of July 31st, there was short interest totalling 2,430,000 shares, a growth of 5.7% from the July 15th total of 2,300,000 shares. Approximately 12.2% of the company’s stock are short sold. Based on an average trading volume of 244,600 shares, the days-to-cover ratio is currently 9.9 days.
Fractyl Health Trading Up 1.7 %
Shares of NASDAQ:GUTS traded up $0.04 during trading hours on Friday, hitting $2.39. The company’s stock had a trading volume of 227,719 shares, compared to its average volume of 292,404. The company’s fifty day moving average is $4.06. Fractyl Health has a 52 week low of $1.74 and a 52 week high of $14.50. The company has a debt-to-equity ratio of 0.34, a quick ratio of 9.37 and a current ratio of 9.38.
Fractyl Health (NASDAQ:GUTS – Get Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.36) EPS for the quarter, topping analysts’ consensus estimates of ($0.46) by $0.10. The business had revenue of $0.04 million during the quarter. Equities analysts anticipate that Fractyl Health will post -2.03 EPS for the current fiscal year.
Institutional Investors Weigh In On Fractyl Health
Fractyl Health Company Profile
Fractyl Health, Inc, a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.
Featured Stories
- Five stocks we like better than Fractyl Health
- What Are Trending Stocks? Trending Stocks Explained
- This Small Cap Wealth Management Stock Could Provide Big Returns
- Technology Stocks Explained: Here’s What to Know About Tech
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- How to Buy Cheap Stocks Step by Step
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for Fractyl Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fractyl Health and related companies with MarketBeat.com's FREE daily email newsletter.